DELIVER-MS work highlighted with a Neurology podcast and editorial titled Making public and patient involvement in clinical trials more than aspirational (https://cp.neurology.org/content/10/3/188). This commentary refers to our article: Achieving effective patient and public involvement in international clinical trials in neurology (https://cp.neurology.org/content/10/3/265).

Based on feedback from DELIVER-MS investigators and participants, who have told us how helpful they find the www.deliver-ms.com website, we have developed a QR code. Do feel free to print and share.  

DELIVER-MS investigators may wish to listen to the JAMA Clinical Reviews podcast on Understanding Pragmatic Trials, which was released in June 2020 and has much relevance to DELIVER-MS (https://edhub.ama-assn.org/jn-learning/audio-player/18519549)

The MS Society UK did a follow-up piece on the equipoise between EHT and escalation (https://www.mssociety.org.uk/research/latest-research/latest-research-news-and-blogs/is-early-intensive-treatment-best).

The DELIVER-MS trial was featured in an article in the Research Matters publication this month, which circulates to 35,000 people affected by MS (https://www.mssociety.org.uk/research/latest-research/latest-research-news-and-blogs/is-early-intensive-treatment-best)